Search

everythinglearnresearchcommunity

for

Search:↓

14,15-EET may help reduce poststroke pain by affecting certain brain proteins.

Delta-opioid receptors affect skin cell circadian rhythms, possibly impacting wound healing and cancer.

GPR40 agonists help hair growth through the protein ANGPTL4.

Finasteride boosts morphine's pain relief, stops tolerance, and reduces withdrawal in rats.

Paroxetine relieves pain by increasing allopregnanolone levels.

Oestrogen and thyrotropin-releasing hormone affect prolactin and its receptor in human skin and hair, suggesting new treatment options for related conditions.

Finding functions for unknown GPCRs is hard but key for making new drugs.

The document concludes that more research is needed to understand how to treat muscle pain with drugs.

Tamsulosin is a cost-effective treatment for BPH symptoms.

PEA reduces pain by increasing neurosteroid synthesis in the spinal cord.

PPAR agonists show promise for skin conditions but need more research before being a main treatment.

A compound made by Pfizer can potentially stimulate hair growth and reduce oil production, making it a good candidate for topical use.

Both finasteride and GnRH agonist treatments reduced hair growth in women with idiopathic hirsutism, but GnRH agonist was more effective.

Different substances that activate or block the androgen receptor can affect male development and treat conditions like prostate cancer.

The PDGF/PDGFR pathway is a potential drug target with mixed success in treating various diseases, including some cancers and fibrosis.

Dyclonine can effectively reduce skin issues by inhibiting the TRPV3 channel.

GnRH analogue can help diagnose ovarian causes of high testosterone in postmenopausal women when scans don't show the cause.

Inhibiting testosterone 5alpha-reductase may help treat benign prostatic hyperplasia.

Certain peptides can prevent hair loss in young rats caused by a cancer drug.

New drugs like N-acetylcysteine and dronabinol show promise for treating hair-pulling disorder.

Prostanoids, like prostaglandins and thromboxane A2, can both enhance and inhibit hair growth, and understanding their effects could help treat hair disorders.

Chronic GnRHa treatment can help manage endometrial hyperplasia and reduce ovarian androgen excess in PCO patients.

Finasteride boosts morphine's pain relief and prevents tolerance and withdrawal in rats.

TRPA1 is crucial for mechanical sensitivity in skin sensory neurons.

New hormonal treatments for enlarged prostate show promise for safer, effective non-surgical options.

Lysophosphatidic acid affects sensory neurons and may cause neuropathic pain and itch.

Activating δ-opioid receptors can help hair grow.

Higher substance P levels may cause discomfort in hair loss patients.

Adding aripiprazole to the treatment improved hair-pulling symptoms in a teenager.

A woman's excessive hair growth around a leg ulcer was linked to a treatment with Prostaglandin E1 ointment.